44
IRUS Total
Downloads
  Altmetric

No need for lopinavir dose adjustment during pregnancy: a population pharmacokinetic and exposure-response analysis in pregnant and nonpregnant HIV-infected subjects

File Description SizeFormat 
Kaletra Pregnancy manuscript submitted version.docxAccepted version123.68 kBMicrosoft WordView/Open
Figure 1.tifAccepted version142.08 kBTIFFView/Open
Figure 2.tiffAccepted version113.82 kBTIFFView/Open
Figure 3.tifAccepted version101.67 kBTIFFView/Open
Figure 4.tifAccepted version110.94 kBTIFFView/Open
Title: No need for lopinavir dose adjustment during pregnancy: a population pharmacokinetic and exposure-response analysis in pregnant and nonpregnant HIV-infected subjects
Authors: Salem, AH
Jones, AK
Santini-Oliveira, M
Taylor, GP
Patterson, KB
Nilius, AM
Klein, CE
Item Type: Journal Article
Issue Date: 2-Nov-2015
Date of Acceptance: 24-Oct-2015
URI: http://hdl.handle.net/10044/1/34136
DOI: http://dx.doi.org/10.1128/AAC.01197-15
ISSN: 1098-6596
Publisher: American Society for Microbiology
Start Page: 400
End Page: 408
Journal / Book Title: Antimicrobial Agents and Chemotherapy
Volume: 60
Issue: 1
Copyright Statement: © 2015, American Society for Microbiology. All Rights Reserved.
Sponsor/Funder: Abbott Laboratories Ltd (UK)
Abbott Laboratories Ltd (UK)
Funder's Grant Number: None
N/A
Keywords: Science & Technology
Life Sciences & Biomedicine
Microbiology
Pharmacology & Pharmacy
HUMAN-IMMUNODEFICIENCY-VIRUS
TABLET FORMULATION
PROTEIN-BINDING
3RD TRIMESTER
LOPINAVIR/RITONAVIR TABLETS
PLASMA-CONCENTRATIONS
TROUGH CONCENTRATIONS
ANTIRETROVIRAL-NAIVE
HIV-1-INFECTED WOMEN
SAFETY
0605 Microbiology
1108 Medical Microbiology
1115 Pharmacology And Pharmaceutical Sciences
Publication Status: Published
Appears in Collections:Department of Medicine (up to 2019)